Budding Opportunities: Investing in Eve&Co.

Eve&Co is a Canadian producer of cannabis under the MMPR in Southwestern Ontario and is licensed under Natural MedCo.

If you are interested in investing in Eve&Co please send a detailed email to invest@naturalmedco.ca

We look forward to hearing from you!

Latest Press Releases from Eve and Co.

Natural MedCo Receives Sales License for Medicinal Cannabis and Announces New “Eve” Brand

 TORONTO, June  25, 2018  (GLOBE NEWSWIRE) -- Carlaw Capital V Corp.  ("Carlaw") (NEX:CVC.H) is pleased to announce that 1600978 Ontario Inc.  (which operates as Natural MedCo) (the "Company") has been granted  permission to sell medicinal cannabis under the Access to Cannabis for Medical Purposes Regulations.  It is expected that such sales permission will automatically extend to  allow the Company to conduct recreational cannabis sales once legal  under the Cannabis Act, which the federal government has announced will occur on October 17, 2018.
 

As previously announced, the Company and Carlaw have entered into an  amalgamation agreement pursuant to which the Company and a wholly-owned  subsidiary of Carlaw will amalgamate (the "Amalgamation"). Upon  completion of the Amalgamation, it is the intention of the parties that  Carlaw will be renamed "Eve & Co Incorporated" ("Eve & Co") and  continue to carry on the medicinal cannabis business of the Company.

Eve & Co is also intending to position itself, under its  new "Eve" brand, as a premier, female and wellness-focused cannabis  brand in the recreational market. Eve & Co expects to provide  educational information and online support for its customers and  first-time buyers. Eve & Co will also work through market outreach  and education to destigmatize cannabis consumption among women.

It is expected that Eve & Co will continue to serve the medicinal cannabis market through its Natural MedCo brand as well.

"We believe that Canadian women want a brand they can trust and  feel connected to. We're aiming to be the premier Canadian cannabis  brand for women in the consumer sector, who will soon be walking into  provincial cannabis stores this October. We're hoping Eve's message of  female empowerment and leadership will resonate, and more importantly,  help establish meaningful relationships with the consumers who use our  products", commented Melinda Rombouts, President and Chief Executive  Officer of the Company.

Further information about the Amalgamation and Natural MedCo is available on Carlaw's SEDAR profile at www.sedar.com.

About Natural MedCo

Natural MedCo received its license on July 22, 2016 under the Marihuana for Medical Purposes Regulations (MMPR), and is now a licensed producer of dried cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Natural MedCo was Canada's 34th licensed producer and first female-founded licensed producer.

Natural MedCo is led by a team of agricultural experts and has a  120,000 sq. ft. scalable greenhouse production facility located in  Middlesex County, Ontario with 32 acres of adjacent land for future  expansion. Natural MedCo is currently working towards the completion of  its ‘Phase One' greenhouse expansion, which will add an additional  100,000 sq. ft. and is expected to be completed by the end of this  month, and has broken ground on an additional 780,000 sq. ft. ‘Phase  Two' expansion, bringing Natural MedCo's total anticipated greenhouse  capacity to 1,000,000 sq. ft.

About Carlaw Capital V Corp.

Carlaw is a capital pool company formed under the TSX Venture  Exchange (the "TSXV") Capital Pool Company program. Material information  about Carlaw can be found on SEDAR under Carlaw's issuer profile at www.sedar.com.

The TSXV has neither approved nor disapproved the contents of  this news release. Neither the TSXV nor its Regulation Service Provider  (as that term is defined in the policies of the TSXV) accepts  responsibility for the adequacy or accuracy of this release. 

Certain statements in this press release constitute  forward-looking information. All statements other than statements of  historical fact contained in this press release, including, without  limitation, those regarding the Carlaw's future, strategy, plans,  objectives, goals and targets, and any statements preceded by, followed  by or that include the words "believe", "expect", "aim", "intend",  "plan", "continue", "will", "may", "would", "anticipate", "estimate",  "forecast", "predict", "project", "seek", "should" or similar  expressions or the negative thereof, are forward-looking statements.  These statements are not historical facts but instead represent only the  Carlaw's expectations, estimates and projections regarding future  events. These statements are not guarantees of future performance and  involve assumptions, risks and uncertainties that are difficult to  predict. Therefore, actual results may differ materially from what is  expressed, implied or forecasted in such forward-looking statements. 

Additional factors that could cause actual results,  performance or achievements to differ materially include, but are not  limited to: Carlaw and Natural MedCo's ability to complete the  Amalgamation and Natural MedCo's ability to complete sales into the  recreational market or at all. Additional information identifying risks  and uncertainties is contained in the Carlaw's filings with Canadian  securities regulators, and available at www.sedar.com.  Management provides forward-looking statements because it believes they  provide useful information to investors when considering their  investment objectives and cautions investors not to place undue reliance  on forward-looking information. Consequently, all of the  forward-looking statements made in this press release are qualified by  these cautionary statements and other cautionary statements or factors  contained herein, and there can be no assurance that the actual results  or developments will be realized or, even if substantially realized,  that they will have the expected consequences to, or effects on, the  Carlaw. These forward-looking statements are made as of the date of this  press release and the Carlaw assumes no obligation to update or revise  them to reflect subsequent information, events or circumstances or  otherwise, except as required by law.

 

Local Business Becomes 34th Licensed Producer of Marihuana in Canada

 Natural Med Co. becomes the 34th Licensed Producer of Medicinal Marihuana in Canada
Middlesex  County, July 23, 2016 – The Natural Med Company is pleased to announce  that it has become the 34th facility in Canada to be approved as a  Licensed Producer under the Marihuana for Medical Purposes Regulations  (MMPR) program. Natural Med Co. received notification dated July 22,  2016 that a license had been issued to allow cultivation of cannabis  plants.
Natural Med Co. is a 120,000 square foot greenhouse located  outside of London and becomes the second largest producer under the MMPR  in licensed square footage. It features the most advanced security and  automated systems for each step of growth and production.
They have a  unique, all natural approach. As greenhouse growers, they take full  advantage of natural light to grow the healthiest plants and product  without the use of hormones.
With one of  the largest growing spaces, Natural Med Co. will be able to offer the  best selection of strains for their clients’ needs. Large scale  greenhouse production will also enable them to produce efficiently and  offer competitive pricing.
As one of the very few Licensed Producers  with women leadership, they have a unique perspective on women’s health  and will offer additional support to help women in their health choices  and for their families